$39.75
arrow_drop_up2.23%Key Stats | |
---|---|
Open | $38.98 |
Prev. Close | $38.88 |
EPS | -3.57 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 38.05 | 39.97 |
52 Week Range | 19.83 | 73.80 |
Ratios | |
---|---|
EPS | -3.57 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Apellis (APLS) Falls on Second Negative CHMP Opinion for GA Drug
What Analysts Are Saying About Apellis Pharmaceuticals Stock
Apellis Plans to Seek Re-Examination Following Negative CHMP Opinion for Pegcetacoplan for Geographic Atrophy (GA) in the EU
Apellis (APLS) Up on Upbeat GA Data From Long-Term Syfovre Study
Why Is Apellis Pharmaceuticals (APLS) Down 1.9% Since Last Earnings Report?
Apellis Pharmaceuticals to Host a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.